相关实验视频
Updated: Jul 3, 2025

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
持续的糖尿病缓解尽管体重复发:胃绕道术 长期代谢益处
Omar M Ghanem1, Kamal Abi Mosleh1, Anthony Kerbage2
1From the Department of Surgery (Ghanem, Abi Mosleh, Hage), Mayo Clinic, Rochester, MN.
Journal of the American College of Surgeons
|February 13, 2024
概括
鲁克斯-en-Y胃绕道 (RYGB) 维持了2型糖尿病 (T2DM) 缓解,即使体重复发,这表明体重减轻独立的好处. 袖子胃切除术 (SG) 显示了更低的缓解率和更高的复发率.
科学领域:
- 腹腔外科手术是什么意思
- 代谢性疾病研究研究.
- 内分泌学 在内分泌学.
背景情况:
- 鲁克斯-en-Y胃绕道 (RYGB) 提供了高的2型糖尿病 (T2DM) 缓解率,通常归因于减肥.
- 袖子胃切除术 (SG) 缺乏近道肠道旁路,这引发了关于RYGB的重量独立T2DM缓解机制的问题.
研究的目的:
- 为了比较RYGB和SG后的持续糖尿病缓解率 (CDR),特别是检查体重复发 (WR) 的影响.
- 调查RYGB后T2DM缓解的潜在体重减轻独立机制.
主要方法:
- 对BMI≥35kg/m2和T2DM患者进行回顾性审查,这些患者接受了初级RYGB或SG.
- 纳入标准:≥5年随访,有记录的WR和初始T2DM缓解.
- 根据WR四分位数对CDR率进行了分层,并对RYGB和SG队列进行了比较.
主要成果:
- RYGB的CDR (75%) 比SG (34.8%;p < 0.001) 显著高得多.
- 与RYGB相比,在SG后T2DM复发的几率是SG后的5.5倍.
- 即使在RYGB之后有显著的WR (60%为>75%的WR),CDR仍然很大,WR与T2DM复发无关.
结论:
- RYGB促进了独立于体重减轻的持续T2DM缓解,突出了近端小肠绕道的作用.
- 这些发现支持RYGB在T2DM管理中的体重减轻独立的代谢优势.
相关概念视频
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Glucagon-like Receptor Agonists
322
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
322
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Metabolic States of the Body: The Postabsorptive State
314
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
314
Pathophysiology of Diabetes
937
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
937
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201

